A New Cutting-Edge Biotech Player Joins Hungary’s Pharmaceutical Landscape
2025. 04. 25.
Hungary continues to strengthen its position in the pharmaceutical industry as Singapore-based Hongene Biotech announces the establishment of its first European manufacturing facility in Gödöllő. The nearly EUR 94 million greenfield investment will create 150 new jobs and contribute significantly to Hungary’s export performance.
Hongene Biotech Corporation, with close to 30 years of experience, is a key global player in the specialized field of nucleic acid production. The company is a world leader in the manufacturing of phosphoramidites and holds a leading position in producing raw materials for mRNA and oligonucleotide products. Since 2021, Hongene has played an important role in the global fight against COVID-19 by supplying large quantities of materials used in mRNA vaccines. Employing over 1,600 professionals worldwide, with a 400-member R&D team, the company has a strong presence in the United States, Japan, and China.
Gödöllő was selected as the site of Hongene’s first European manufacturing base. The greenfield investment will cover a 15-hectare area and include a facility of over 10,000 square meters, housing pharmaceutical ingredient production, quality assurance, environmental protection, warehousing, and utility infrastructure.
Production at the facility will focus on exports, making a meaningful contribution to Hungary’s export economy.
Sector articles
Hungarian nuclear medicine supplier Medi-Radiopharma is launching an R&D investment to develop a pioneering manufacturing technology.
2026. 03. 30.
MedTech #MedTechThe foundation stone has been laid for the sterilization plant in Környe. The €42.2 million project will create 25 high value-added jobs.
2026. 02. 09.
MedTech #MedTechMedicontur, a Hungarian company recognized on the global market of manufacturers specializing in the development of medical devices, is further expanding its domestic presence. As part of its latest investments totaling EUR 20.8 million, the company will expand ...
2026. 01. 22.
MedTech #MedTech